Epidemiological data and treatment strategies in children with severe haemophilia in Italy

• Published in: Annali dell'Istituto superiore di sanita Vol. 56; no. 4; p. 437
• Main Authors: Abbonizio, Francesca, Hassan, Hamisa J, Santagostino, Elena, Arcieri, Romano, Biffoni, Mauro, Giampaolo, Adele
• Format: Journal Article
• Language: English
• Published: Italy Istituto Superiore di Sanità 01.01.2020
• Subjects: Hemophilia; Italy
• ISSN: 0021-2571; 2384-8553
• DOI: 10.4415/ANN_20_04_05

In a period of important therapeutic changes in the field of haemophilia care, we provide updated statistics on children with severe haemophilia (0-12 years of age) in Italy. Data presented are from the Italian National Registry of Congenital Coagulopathies (NRCC) - survey 2017. Children with severe Haemophilia A (HA) were 242, those with severe haemophilia B (HB) 48. Prophylaxis was adopted in 92.1% of individuals with severe HA and 88.6% with severe HB. Thirty-nine children (14.8%) were on treatment for inhibitors. FVIII prescribed to children with severe HA represented 11.1% of the total consumption, of which 4.6% was extended half-life (EHL). FIX given to children with HB accounted for 7.2% of the total FIX, of which 19.1% was EHL-FIX. The paediatric population analysed is characterized by a great adherence to therapy, so this data may constitute a benchmark for use of new, alternative therapies in the coming years.